Doryx

This page contains recent news articles, when available, and an overview of Doryx but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.


Overview:

Doryx
(when available)

Pharmacology and use:
Doxycycline, a long-acting tetracycline derived from oxytetracycline, is used to inhibit bacterial protein synthesis and treat non-gonococcal urethritis and cervicitis, exacerbations of bronchitis in patients with COPD, and adult periodontitis. For the treatment of the following infections:Rocky mountain spotted fever, typhus fever and the typhus group, Q fever, rickettsialpox, and tick fevers caused by Rickettsiae, Chancroid caused by Haemophilus ducreyi, Uncomplicated gonorrhea caused by Neisseria gonorrhoeae, Respiratory tract infections caused by Mycoplasma pneumoniae or Streptococcus pneumoniae. Lymphogranuloma ve

Mechanism Of Action:
Doxycycline, like minocycline, is lipophilic and can pass through the lipid bilayer of bacteria. Doxycycline reversibly binds to the 30 S ribosomal subunits and possibly the 50S ribosomal subunit(s), blocking the binding of aminoacyl tRNA to the mRNA and inhibiting bacterial protein synthesis.

News Articles on Doxycycline

Collins Stewart Initiates Coverage on Impax Labs (IPXL) with a Buy; Strong ...  -  ‎Dec 15, 2009‎
Several key exclusive generic opportunities (Adderall XR, Flomax, Opana ER, Renvela, Doryx 150mg, Detrol LA and Effexor XR) provide a bridge between the ... StreetInsider.com (subscription)

Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2009  -  ‎Nov 9, 2009‎
Net sales of DORYX increased $3.4 million, or 7.6%, in the quarter ended September 30, 2009, compared to the prior year quarter, primarily due to a 45.2% ... CNNMoney.com (press release)

Warner Chilcott gets FDA nod for Doryx 150mg tablets  -  Jun 23, 2008
June 23 (Reuters) - Warner Chilcott Ltd (WCRX.O) said it received approval from the US Food and Drug Administration for the 150mg dosage of its Doryx ... Reuters UK

Chronic sinusitis  -  Oct 11, 2008
Antibiotics used to treat chronic sinusitis caused by a bacterial infection include amoxicillin (Amoxil, Trimox, others), doxycycline (Doryx, Monodox, ... CNN International

Warner Chilcott Files Lawsuits for Infringement of DORYX(R) Patent  -  Dec 23, 2008
ST. DAVID'S, Bermuda , Dec. 23 /PRNewswire-FirstCall/ -- Warner Chilcott Limited (Nasdaq: WCRX) announced today that one of its subsidiaries and Mayne ... RedOrbit

New and generic drug approvals: Doryx (doxycycline hyclate) delayed- …  -  Dec 26, 2006
On 26 Dec 2006, the US Food and Drug Administration announced approval of NDA 050795 (efficacy supplement with clinical data) for Doryx (doxycycline ... Pay-Per-View - US Food and Drug Administration News - Factiva, from Dow Jones

Warner Chilcott issues 2008 outlook  -  Jan 28, 2008
Warner projects 2008 revenue of $935 million to $945 million, primarily driven by oral contraceptive Loestrin 24 FE, acne drug Doryx, oral contraceptive ... Boston Globe

WARNER CHILCOTT LIMITED at Morgan Stanley Pharmaceutical CEOs …  -  Jan 4, 2007
UNIDENTIFIED PARTICIPANT: Doryx has been losing share to Solodyn. ... And so we have to, we have to give the sales reps a bit more with Doryx and we have to ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com

Doryx.(Drug overview)  -  Jan 22, 2007
Doxycycline is a broad-spectrum tetracycline antibiotic used against a wide variety of bacterial infections, including Rocky Mountain spotted fever and ... Free with registration - PDR Family Guide to Prescription Drugs - AccessMyLibrary.com

IMPAX Sued Based on ANDA for Generic Doryx®  -  Dec 31, 2008
IMPAX Laboratories, Inc. today announced that Warner Chilcott Laboratories Ireland Limited, Warner Chilcott Company, Inc., Warner Chilcott (US) LLC, ... International Business Times

… Warner Chilcott Files Lawsuits for Infringement of DORYX(R)...  -  Dec 23, 2008
Warner Chilcott Files Lawsuits for Infringement of DORYX(R) Patent. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research

Doryx DR approved.(RXs)(Warner Chilcott Inc.'s Doryx gets FDA...  -  Jul 14, 2008
Doryx DR approved.(RXs)(Warner Chilcott Inc.'s Doryx gets FDA approval)(Brief article) ... find Chain Drug Review articles. Warner Chilcott Ltd. has ... Pay-Per-View - Chain Drug Review - HighBeam Research

Doryx DR approved.  -  Jul 14, 2008
Doryx DR approved. Warner Chilcott Ltd. has received FDA approval for a 150-mg strength of Doryx (doxycycline hyclate) delayed-release tablets. ... $9.94 - Chain Drug Review - Alacra Store

Warner Chilcott Reports Operating Results for the Quarter Ended June...  -  Aug 10, 2007
Net sales of DORYX increased $2.9 million, or 11.4% in the quarter ended June ... DORYX prescriptions, which had been growing during the period from July 1, ... Free with registration - PR Newswire - AccessMyLibrary.com

Press Release: Barr Announces Warner Chilcott Waives Exclusive …  -  Sep 26, 2006
Warner Chilcott believes that ... of Impax's generic version of DORYX 150 ... Application (ANDA) for a generic version of DORYX 150 mg delayed ... tablets. ... Pay-Per-View - PR Newswire - HighBeam Research

Warner Chilcott Reports Operating Results for the Quarter Ended June...  -  Jun 30, 2007
Net sales of DORYX increased $2.9 million, or 11.4% in the quarter ended June ... DORYX prescriptions, which had been growing during the period from July 1, ... prnewswire.com

FINAL TRANSCRIPT  -  May 9, 2008
...by the sales of our key promoted products, Loestrin 24, Doryx, Taclonex and Femcon. ... Doryx were 35.1 million in the first quarter of '08, representing a ... $54.00 - Thomson StreetEvents - Alacra Store

Warner Chilcott Reports Results for the Quarter and Nine Months ended...  -  Sep 30, 2005
Sales of our oral antibiotic for acne, DORYX(R), increased $6.5 million (+39.4%) ... Total prescriptions for DORYX(R) in the quarter increased slightly in ... prnewswire.com

Warner Chilcott Reports Operating Results for the Year and the...  -  Dec 31, 2005
In dermatology, sales of our oral antibiotic for acne, DORYX(R), ... The levels of wholesale pipeline inventories of DORYX(R) are expected to remain at ... prnewswire.com

Warner Chilcott Reports Operating Results for the Quarter and Six...  -  Jun 30, 2006
DORYX(R) prescriptions returned to growth in the second half of 2005 as the ... Filled prescriptions for DORYX(R) in the quarter and six months ended June ... prnewswire.com

Warner Chilcott Reports Operating Results for the Quarter Ended March...  -  May 11, 2007
Sales of DORYX increased $1.4 million, or 5.6%, compared to the prior year quarter. DORYX prescriptions, which had been growing during the period from July ... $4.95 - PR Newswire - ECNext

Warner Chilcott Reports Results for the Quarter and Nine Months ended...  -  Nov 11, 2005
Sales of our oral antibiotic for acne, DORYX(R), increased $6.5 million (+39.4%) ... Total prescriptions for DORYX(R) in the quarter increased slightly in ... $4.95 - PR Newswire - ECNext

Warner Chilcott Reports Operating Results for the Quarter and Six...  -  Aug 11, 2006
DORYX(R) prescriptions returned to growth in the second half of 2005 as the ... Filled prescriptions for DORYX(R) in the quarter and six months ended June ... $4.95 - PR Newswire - ECNext

Warner Chilcott Reports Operating Results for the Quarter and Year …  -  Dec 31, 2007
Sales of DORYX increased $4.5 million, or 16.4%, in the quarter ended December 31 ... DORYX prescriptions had been declining through the first half of 2007. ... prnewswire.com

… Warner Chilcott Ltd будет выпуÑ?кать антибиотик Doryx в новой до?  -  Jun 25, 2008
Ð?мериканÑ?каÑ? фармкомпаниÑ? Warner Chilcott Ltd получила разрешение УправлениÑ? по качеÑ?тву продуктов и медикаментов СШÐ? (FDA) на маркетинг препарата Doryx ... ФармацевтичеÑ?кий веÑ?тник

Warner Chilcott Reports Operating Results for the Year and the...  -  Mar 29, 2006
In dermatology, sales of our oral antibiotic for acne, DORYX(R), ... The levels of wholesale pipeline inventories of DORYX(R) are expected to remain at ... $4.95 - PR Newswire - ECNext

Warner Chilcott Reports Operating Results for the Quarter Ended …  -  Nov 9, 2007
Net sales of DORYX increased $4.6 million, or 18.7%, in the quarter ended ... DORYX prescriptions had been declining through the first half of 2007. ... $4.95 - PR Newswire - ECNext

Q4 2007 WARNER CHILCOTT LIMITED Earnings Conference Call - Final …  -  Feb 29, 2008
Also in dermatology, net sales of Doryx were $31.6 million in fourth quarter of '07 ... Our efforts of Doryx were diluted by the launch of Taclonex, ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com

Warner Chilcott Reports Operating Results for the Quarter ended March...  -  Mar 31, 2006
In dermatology, net sales of DORYX(R), increased $1.1 million (+4.5%). Prescription demand in the quarter increased more than 10% compared with the prior ... prnewswire.com

Warner Chilcott Reports Results for The Quarter Ended March 31, 2005.  -  Jun 28, 2005
Also in May, the Company's NDA for two strengths of delayed-release DORYX(R) tablets was approved by the FDA. The Company expects to launch the new DORYX(R) ... $4.95 - PR Newswire - ECNext

Warner Chilcott Reports Operating Results for the Quarter and Year …  -  Dec 31, 2006
Sales of DORYX decreased $4.7 million, or 14.8%, in the quarter compared to the ... Filled prescriptions for DORYX began to decline in the third quarter of ... prnewswire.com

Warner Chilcott Reports Operating Results for the Quarter ended March...  -  May 15, 2006
In dermatology, net sales of DORYX(R), increased $1.1 million (+4.5%). Prescription demand in the quarter increased more than 10% compared with the prior ... Free with registration - PR Newswire - AccessMyLibrary.com

Warner Chilcott Reports Operating Results for the Quarter and Year …  -  Mar 7, 2007
Sales of DORYX decreased $4.7 million, or 14.8%, in the quarter compared to the ... Filled prescriptions for DORYX began to decline in the third quarter of ... $4.95 - PR Newswire - ECNext

Press Release: Warner Chilcott Reports Operating Results for the...  -  May 15, 2006
In dermatology, net sales of DORYX(R), increased $1.1 million (+4.5%). Prescription demand in the quarter increased more than 10% compared with the prior ... Pay-Per-View - PR Newswire - HighBeam Research

Warner Chilcott Reports Results for the Quarter and Six Months ended ...  -  Jun 30, 2005
Sales of our oral antibiotic DORYX(R) (-$1.6 million, -9.0%) and hormone therapy product ESTRACE(R) CREAM (-$4.0 million, -26.6%) declined mainly due to ... prnewswire.com

Warner Chilcott Announces Receipt of Paragraph IV Certification...  -  Dec 8, 2008
DORYX, which the Company markets and sells in 150, 100 and 75 mg strengths in the United States under a license agreement with Hospira's subsidiary, ... RedOrbit

Press Release: Warner Chilcott Announces Receipt of Paragraph IV …  -  Dec 8, 2008
DORYX, which the Company markets and sells in 150, 100 and 75 mg strengths in the United States under a license agreement with Hospira's subsidiary, ... Pay-Per-View - PR Newswire - HighBeam Research

New Warner Chilcott posts 1st-qtr loss.(Warner Chilcott Holdings)  -  Jul 11, 2005
Also in May, the company's NDA for two strengths of delayed-release Doryx tablets was approved by the FDA and the group anticipates launching the new ... $4.95 - Pharma Marketletter - ECNext

Warner Chilcott Reports Results for the Quarter and Six Months ended ...  -  Aug 16, 2005
Sales of our oral antibiotic DORYX(R) (-$1.6 million, -9.0%) and hormone therapy product ESTRACE(R) CREAM (-$4.0 million, -26.6%) declined mainly due to ... $4.95 - PR Newswire - ECNext

Common and alternate oral antibiotic therapies for acne vulgaris: a...  -  Sep 1, 2007
Doryx was shown to result in fewer gastrointestinal side effects when compared to capsules containing the powdered form.(10) ... Free with registration - Journal of Drugs in Dermatology - AccessMyLibrary.com

Warner Chilcott Reports Operating Results for the Quarter ended …  -  Nov 14, 2006
Sales of DORYX(R) increased $1.5 million, or 6.6%, in the quarter ended September ... Filled prescriptions for DORYX(R), which had been growing during the ... $4.95 - PR Newswire - ECNext

Merger and Acquisition Scenario  -  Apr 7, 2007
Doryx (Doxycycline Hyclate); Estrostep Fe (Norethindrone Acetate/Ethinyl Estradiol); Dovonex (Calcipotriene); Taclonex (Calcipotriene/Betamethasone ... $250.00 - Revere Reports - Revere

Suppliers keep new products coming.(Impax Laboratories Inc.'s Salagen...  -  May 1, 2006
Article: Doryx DR approved.(RXs)(Warner Chilcott Inc.'s Doryx gets ... Chain Drug Review; July 14, 2008 ; 609 words ...Warner Chilcott Ltd. has received FDA ... Pay-Per-View - Chain Drug Review - HighBeam Research

Merger and Acquisition Scenario  -  Jun 23, 2007
Doryx (Doxycycline Hyclate); Estrostep Fe (Norethindrone Acetate/Ethinyl Estradiol); Dovonex (Calcipotriene); LEO 80-185 (Calcipotriene/Betamethasone ... $250.00 - Revere Reports - Revere

Special to CNN.com  -  Nov 23, 2005
Drugs most commonly used to treat epididymitis include ceftriaxone (Ceftin), ciprofloxacin (Cipro), doxycycline (Doryx, Vibramycin), ... cnn.com

Merger and Acquisition Scenario  -  May 19, 2007
Doryx (Doxycycline Hyclate); Estrostep Fe (Norethindrone Acetate/Ethinyl Estradiol); Dovonex (Calcipotriene); Taclonex (Calcipotriene/Betamethasone ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Sep 23, 2006
Doryx (Doxycycline Hyclate); Estrostep Fe (Norethindrone Acetate/Ethinyl Estradiol); Dovonex (Calcipotriene); Taclonex (Calcipotriene/Betamethasone ... $250.00 - Revere Reports - Revere

WARNER CHILCOTT LIMITED at Morgan Stanley Pharmaceutical CEOs …  -  Jan 4, 2008
People are a little bit surprised that like Doryx is coming back, but that is not a surprise because all it was was sales rep execution and focus. ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com

Merger and Acquisition Scenario  -  Sep 23, 2006
Doryx (Doxycycline Hyclate); Estrostep Fe (Norethindrone Acetate/Ethinyl Estradiol); Dovonex (Calcipotriene); Taclonex (Calcipotriene/Betamethasone ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Jun 16, 2007
Doryx (Doxycycline Hyclate); Estrostep Fe (Norethindrone Acetate/Ethinyl Estradiol); Dovonex (Calcipotriene); LEO 80-185 (Calcipotriene/Betamethasone ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Jan 27, 2007
Doryx (Doxycycline Hyclate); Estrostep Fe (Norethindrone Acetate/Ethinyl Estradiol); Dovonex (Calcipotriene); Taclonex (Calcipotriene/Betamethasone ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Jun 30, 2007
Doryx (Doxycycline Hyclate); Estrostep Fe (Norethindrone Acetate/Ethinyl Estradiol); Dovonex (Calcipotriene); Taclonex (Calcipotriene/Betamethasone ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Jan 26, 2008
Doryx (Doxycycline Hyclate); Estrostep Fe (Norethindrone Acetate/Ethinyl Estradiol); Dovonex (Calcipotriene); Taclonex (Calcipotriene/Betamethasone ... $250.00 - Revere Reports - Revere

Warner Chilcott, Inc. - Company Snapshot - AlacraStore.com  -  Dec 10, 2008
Doryx DR approved. Chain Drug Review, Jul 14 2008, $9.95 …Warner Chilcott Ltd. has received FDA approval for a ###-mg strength of Doryx (doxycycline ... Pay-Per-View - co - Alacra Store

Merger and Acquisition Scenario  -  Nov 29, 2008
Doryx (Doxycycline Hyclate Delayed Release); Estrostep Fe (Norethindrone Acetate/Ethinyl Estradiol); Dovonex (Calcipotriene); Taclonex Scalp Gel ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Aug 16, 2008
Doryx (Doxycycline Hyclate Delayed Release); Estrostep Fe (Norethindrone Acetate/Ethinyl Estradiol); Dovonex (Calcipotriene); Taclonex Scalp Gel ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Nov 22, 2008
Doryx (Doxycycline Hyclate Delayed Release); Estrostep Fe (Norethindrone Acetate/Ethinyl Estradiol); Dovonex (Calcipotriene); Taclonex Scalp Gel ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Oct 25, 2008
Doryx (Doxycycline Hyclate Delayed Release); Estrostep Fe (Norethindrone Acetate/Ethinyl Estradiol); Dovonex (Calcipotriene) ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Jul 26, 2008
Doryx (Doxycycline Hyclate Delayed Release); Estrostep Fe (Norethindrone Acetate/Ethinyl Estradiol); Dovonex (Calcipotriene) ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Dec 27, 2008
Doryx (Doxycycline Hyclate Delayed Release); Estrostep Fe (Norethindrone Acetate/Ethinyl Estradiol); Dovonex (Calcipotriene); Taclonex Scalp Gel ... $250.00 - Revere Reports - Revere

Press Release: Warner Chilcott Reports Operating Results for the...  -  May 9, 2008
The primary drivers of the increase in revenue were the net sales of our promoted products LOESTRIN 24 FE, DORYX, TACLONEX and FEMCON FE, which together ... Pay-Per-View - PR Newswire Europe - HighBeam Research

Press Release: Warner Chilcott Reports Operating Results for the...  -  Nov 10, 2008
The primary drivers of the increase in revenue were the net sales of our promoted products DORYX, LOESTRIN 24 FE, TACLONEX, and FEMCON FE, which together ... Pay-Per-View - PR Newswire - HighBeam Research

Acute sinusitis  -  Oct 13, 2006
...course of antibiotics such as amoxicillin (Amoxil, Trimox), doxycycline (Doryx, Monodox) or the combination drug trimethoprim-sulfamethoxazole (Bactrim, ... cnn.com

Updates, advisories and surprises  -  May 9, 2008
...profit of $33.7 million, or 13 cents a share, with revenue up 5% to $229.5 million, on increased sales of Loestrin 24 FE, Doryx, Taclonex and Femcon FE. ... MarketWatch

Medisin + sol kan være farlig  -  Feb 10, 2005
Doksycyklin (Doryx, Doxylin, Dumoxin, Vibramycin) - brukes mot chlamydiainfeksjoner, lungebetennelse og bronkitt og andre infeksjoner. Kan gi utslett. ... Aftenposten

Warner Chilcott Q3 profit tops estimates, ups '08 view  -  Nov 10, 2008
Sales of Doryx acne treatment soared 53 percent. Shares of the company closed at $13.40 Friday on Nasdaq. For the press release, please click ... Reuters

Clinical experience results with clindamycin 1% benzoyl peroxide 5%...  -  Mar 1, 2005
A regimen of topical clindamycin 1% benzoyl peroxide 5% gel, oral doxycycline hyclate (Doryx[R]), and adapalene gel (Differin[R]) seems especially ... Free with registration - Journal of Drugs in Dermatology - AccessMyLibrary.com

What can I do about MRSA infections?  -  Jan 1, 2008
Bactrim, Septra), tetracyclines (doxycycline [Doryx, Monodox, Vibramycin] or minocycline [Dynacin, Minocin, Myrac]), and clindamycin (Cleocin). 1,3,8 ... Journal of the American Academy of...

Diphenoxylate and Atropine (Systemic).  -  Jul 28, 2005
Antibiotics, such as cephalosporins (eg, Ceftin, Keflex), clindamycin (eg, Cleocin), erythromycins (eg, EES, PCE), tetracyclines (eg, Achromycin, Doryx) ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com

How Do I Control Rosacea?  -  Aug 25, 2007
Doxycycline (Adoxa, Doryx) is generally the most effective but requires strict sun avoidance. While higher doses are typically needed initially, ... Pay-Per-View - Tampa Tribune - ProQuest Archiver

Article: Warner Chilcott shares suspended as takeover becomes...  -  Jan 5, 2005
...therapy brands Estrace and Femring; Sarafem, a prescription treatment for premenstrual dysphoric disorder, and widely prescribed acne drug Doryx. ... Pay-Per-View - AP Worldstream - HighBeam Research

Warner Chilcott第一季转为盈利  -  May 9, 2008
...季度�收增长了5%,至2.30亿美元,主�得益于Loestrin 24 FE�Doryx�Taclonex和Femcon FE等产�销售�的增长。 在调整的基础上,该公�当季�股盈利33美分。 ... 新浪网

Warner Chilcottå?‘布08财年业绩预期  -  Jan 29, 2008
...该公�预计2008财年�收9.35亿-9.45亿美元,主�得益于Loestrin 24 FE�Doryx�Femcon FE和Taclonex这几���的销售�的推动。 新浪声明:本版文章内容纯属作者个人 ... 新浪网

Bellwether Report.com is Tracking Warner Chilcott Ltd.  -  Sep 28, 2006
Other products include dermatology treatments for acne (Doryx) and psoriasis (Dovonex and Taclonex). US subsidiary Warner Chilcott, Inc. makes prescription ... Free with registration - M2 Presswire - AccessMyLibrary.com

Warner Chilcott reports $65.5 million 3rd-qtr loss.(Brief Article)  -  Nov 28, 2005
The group also reports that sales of its acne treatment Doryx (doxycycline) increased $6.5 million, up 39.4% on the year-earlier quarter. ... $4.95 - Pharma Marketletter - ECNext

How to take Acitretin from Consumer Reports Health.  -  Jan 8, 2006
...do not take methotrexate (Rheumatrex, Trexall) or tetracycline antibiotics such as demeclocycline (Declomycin), doxycycline (Doryx, Vibramycin), ... consumerreports.org

How to take Molindone from Consumer Reports Health.  -  Jan 11, 2008
...phenytoin (Dilantin); sedatives; sleeping pills; tetracycline antibiotics such as demeclocycline (Declomycin), doxycycline (Doryx, Monodox, Vibramycin), ... consumerreports.org

Doxycycline for Acne Treatment  -  Sep 1, 2008
It is available in generic formulations as well as brand names (eg Doryx, Vibramycin). It is somewhat less expensive than minocycline. ... Buzzle

How to take Aminolevulinic Acid Topical from Consumer Reports Health.  -  Jan 10, 2007
...and nausea; sulfa antibiotics; and tetracycline antibiotics such as demeclocycline (Declomycin), doxycycline (Doryx, Vibramycin), minocycline (Dynacin, ... consumerreports.org

Difenoxin and Atropine (Systemic).(Drug overview)  -  May 1, 2006
Antibiotics, such as cephalosporins (eg, Ceftin, Keflex), clindamycin (eg, Cleocin), erythromycins (eg, EES, PCE), tetracyclines (eg, Achromycin, Doryx) ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com

Difenoxin and Atropine (Systemic).  -  Aug 1, 2006
Antibiotics, such as cephalosporins (eg, Ceftin, Keflex), clindamycin (eg, Cleocin), erythromycins (eg, EES, PCE), tetracyclines (eg, Achromycin, Doryx) ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com

Accutane.(Drug overview)  -  Jan 22, 2007
Remember, too, that Accutane should not be combined with tetracycline antibiotics such as Doryx, Minocin, and Vibramycin. Accutane causes birth defects; ... Free with registration - PDR Family Guide to Prescription Drugs - AccessMyLibrary.com

IAS: Live Virus Vaccines Touted for HIV  -  Jul 23, 2007
Dr. Berkhout described a technique of creating a form of HIV that can only replicate in the presence of the antibiotic doxycycline (Doryx). ... MedPage Today

576. Help with Rosacea  -  Mar 24, 2008
My daily routine is: in the morning-facial wash and metrogel, then 200mg. of Doryx after a meal, then facial wash and finacea cream at nite. ... nj.com

Erie Times-News : Front Page<br>  -  Oct 27, 2006
Doryx Doxycycline 100mg tab. Vasotec Enalapril 5mg tab. Vasotec Enalapril 10mg tab. Vasotec Enalapril 2.5mg tab. Vasotec Enalapril 20mg tab ... $2.95 - Erie Times-News - NewsBank

Bellwether Report.com Warner Chilcott Ltd.  -  Sep 26, 2006
Other products include dermatology treatments for acne (Doryx) and psoriasis (Dovonex and Taclonex). US subsidiary Warner Chilcott, Inc. makes prescription ... $4.95 - M2 Presswire - ECNext

Press Release: Bellwether Report.com is Tracking Warner Chilcott Ltd....  -  Sep 28, 2006
Other products include dermatology treatments for acne (Doryx) and psoriasis (Dovonex and Taclonex). US subsidiary Warner Chilcott, Inc. makes prescription ... Pay-Per-View - M2 Presswire - HighBeam Research

Press Release: Warner Chilcott Announces Earnings Release Date and …  -  Oct 18, 2007
Warner Chilcott markets and sells DORYX ... CONTACT: Rochelle Fuhrmann, Investor Relations, Warner Chilcott, +1-973-442-3281 ... ... Pay-Per-View - PR Newswire - HighBeam Research

Merger and Acquisition Scenario  -  Jan 6, 2007
Doryx (Doxycycline Hyclate); Estrostep Fe (Norethindrone Acetate/Ethinyl Estradiol); Dovonex (Calcipotriene); Taclonex (Calcipotriene/Betamethasone ... $250.00 - Revere Reports - Revere

Press Release: Warner Chilcott Reports Operating Results for the...  -  Mar 7, 2007
DORYX, TACLONEX and FEMCON FE, which together ... compared to the prior year quarter. The growth ... 0 million in the prior year quarter. ... Pay-Per-View - PR Newswire - HighBeam Research

Merger and Acquisition Scenario  -  Nov 4, 2006
Doryx (Doxycycline Hyclate); Estrostep Fe (Norethindrone Acetate/Ethinyl Estradiol); Dovonex (Calcipotriene); Taclonex (Calcipotriene/Betamethasone ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Dec 16, 2006
Doryx (Doxycycline Hyclate); Estrostep Fe (Norethindrone Acetate/Ethinyl Estradiol); Dovonex (Calcipotriene); Taclonex (Calcipotriene/Betamethasone ... $250.00 - Revere Reports - Revere

Federal Register 2008 - 73 FR 77723 Determination That RUBRAMIN PC …  -  Dec 19, 2008
50 mg/ vial, 150 mg/vial, and 450 mg/vial NDA 50-582 DORYX (doxycycline FH Faulding and Co., c/ hyclate) Delayed-Release o Warner Chilcott, Capsules, ... Pay-Per-View - Federal Register 2008 - Loislaw

Top 300 single-source brand drugs by manufacturer and NDC11 number. …  -  Apr 28, 2008
Doryx 00430011224 263Purdue Pharm.OxyContin 59011010310 264Janssen Risperdal Consta 50458030811 265Abbott Niaspan 60598000301 266MSD Maxalt00006026709 ... Pay-Per-View - Chain Drug Review - HighBeam Research

Merger and Acquisition Scenario  -  May 17, 2008
Doryx (Doxycycline Hyclate Delayed Release); Estrostep Fe (Norethindrone Acetate/Ethinyl Estradiol); Dovonex (Calcipotriene); Taclonex Scalp Gel ... $250.00 - Revere Reports - Revere

Press Release: Warner Chilcott Announces 2008 Financial Guidance. - …  -  Jan 28, 2008
Total revenues for 2008 are expected to be in the range of US$935 to US$945 million, with the growth primarily being driven by LOESTRIN 24 FE, DORYX, ... Pay-Per-View - PR Newswire Europe - HighBeam Research

Merger and Acquisition Scenario  -  Mar 22, 2008
Doryx (Doxycycline Hyclate Delayed Release); Estrostep Fe (Norethindrone Acetate/Ethinyl Estradiol); Dovonex (Calcipotriene) ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Jul 12, 2008
Doryx (Doxycycline Hyclate Delayed Release); Estrostep Fe (Norethindrone Acetate/Ethinyl Estradiol); Dovonex (Calcipotriene) ... $250.00 - Revere Reports - Revere

The majority of drugs dispensed in 2006 were generic.(VITAL SIGNS) | ...  -  Aug 1, 2007
Valtrex 568 Aldara 565 Duac 541 Tazorac 510 Elidel 500 Doryx 429 MetroGel 428 Note: Estimated data based on prescription drugs dispensed by retail ... Pay-Per-View - Skin & Allergy News - HighBeam Research

Press Release: Warner Chilcott Reports Operating Results for the...  -  May 9, 2008
The primary drivers of the increase in revenue were the net sales of our promoted products LOESTRIN 24 FE, DORYX, TACLONEX and FEMCON FE, which together ... Pay-Per-View - M2 Presswire - HighBeam Research

Press Release: Warner Chilcott Reports Operating Results for the Year...  -  Mar 29, 2006
...our sales and marketing teams delivered strong prescription growth for our key products, oral contraceptives OVCON(R) and ESTROSTEP(R), and DORYX(R), ... Pay-Per-View - PR Newswire - HighBeam Research

Press Release: Bellwether Report.com Warner Chilcott Ltd. - M2 …  -  Sep 26, 2006
Other products include dermatology treatments for acne (Doryx) and psoriasis (Dovonex and Taclonex). US subsidiary Warner Chilcott, Inc. makes prescription ... Pay-Per-View - M2 Presswire - HighBeam Research

Brand Names/Synonyms:
Doryx is also known by the following brand names and/or synonymsAlti-Doxycycline; Apo-Doxy; Atridox; DOXCYCLINE ANHYDROUS; Doryx; Doxy 100; Doxy-Caps; Doxy-Lemmon; Doxychel; Doxychel Hyclate; Doxycin; Doxycycline; Doxycycline Hyclate; Doxycycline Monohydrate; Doxylin; Doxytec; Doxytetracycline; GS-3065; Jenacyclin; Monodox; Novo-Doxylin; Nu-Doxycycline; Periostat; Supracyclin; Vibra-Tabs; Vibramycin

Drug Category:
Doryx is categorized under the following by the FDA: Antimalarials; Anti-bacterial Agents; Tetracyclines; ATC:A01AB22; ATC:J01AA02

Dosage Forms:
Tablet; Capsule; Gel; Liquid; Powder; Powder for Solution

Absorption:
completely absorbed after oral administration

Interactions:
[an error occurred while processing this directive]



Chemical IUPAC Name:
2-(amino-hydroxy-methylidene)-4-dimethylamino-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione





Health Home | Conditions | Cancer | Medications | Surgery | Vaccines


The Cancer News Network


Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on cancernewsnetwork.org lead to other sites. cancernewsnetwork.org does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is CancerNewsNetwork.org responsible for dead or misdirected links.

IF YOU NEED A LINK OR TEXT REMOVED FROM THIS PAGE PLEASE CONTACT cancernewsnetwork (at) live.com.
We will do our best to accommodate your request.



COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy